A change of gamma sterilization protocol to accomodate 20% more devices would lead to a significant change under MDR? We are validating this change, would be require to repeat packaging integrity tests after this change in protocol?
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to the use of cookies.